Mito-apocynin (C11) (C007B-374294)

Mito-apocynin (C11), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP + cation. Mito-apocynin (C11) selectively targets mitochondria, and shows neuroprotective effect. Mito-apocynin (C11) prevents hyposmia and corrects deficits in motor function.In VivoMito-apocynin-C11 (3 mg/kg; oral gavage; 3x/wk from 3 months of age until 15 months) markedly improves the coordinated motor function and olfactory function in LRRK2R1441G mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: LRRK2R1441G mice Dosage: 3 mg/kg Administration: Oral gavage; 3x/wk from 3 months of age until 15 months Result: Markedly improved the coordinated motor function and olfactory function.Form:Solid. Specification: 0.99 Molecular Formula: C37H44BrO4P Molecular Weight: 663.62

UPC:

51142544

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

M647341-50mg

CAS:

1254044-38-6

Product Size:

50mg